Ontology highlight
ABSTRACT: Background
Bone morphogenetic protein (BMPs) as a substitute for iliac crest bone graft (ICBG) has been increasingly widely used in lumbar fusion. The purpose of this study is to systematically compare the effectiveness and safety of fusion with BMPs for the treatment of lumbar disease.Methods
Cochrane review methods were used to analyze all relevant randomized controlled trials (RCTs) published up to nov 2013.Results
19 RCTs (1,852 patients) met the inclusion criteria. BMPs group significantly increased fusion rate (RR: 1.13; 95% CI 1.05-1.23, P = 0.001), while there was no statistical difference in overall success of clinical outcomes (RR: 1.04; 95% CI 0.95-1.13, P = 0.38) and complications (RR: 0.96; 95% CI 0.85-1.09, p = 0.54). A significant reduction of the reo
SUBMITTER: Zhang H
PROVIDER: S-EPMC4041715 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature